HCPCS Level II · Outpatient PPS (temporary codes)
C9086Injection, anifrolumab-fnia, 1 mg
Terminated 03/31/2022
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About C9086
C9086 is an HCPCS Level II code in the C series (outpatient PPS (temporary codes)), describing injection, anifrolumab-fnia, 1 mg.
It was added to HCPCS effective 01/01/2022, and its current record took effect 04/01/2022.
It was terminated on 03/31/2022 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Inj, anifrolumab-fnia
- Date added
- 01/01/2022
- Action effective
- 04/01/2022
- Termination date
- 03/31/2022
- BETOS
- O1E
Related C90xx codes
Common questions about C9086
Is HCPCS C9086 still valid?
- No. C9086 was terminated on 03/31/2022.
Does Medicare cover C9086?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.